Swiss Life Private Equity Partners
Other
Active
Zurich, Switzerland
7
439M
6
0.04
0.14
6
- Stages of investment
- Areas of investment
Summary
Swiss Life Private Equity Partners appeared to be the Corporate Investor, which was created in 1857. The leading representative office of defined Corporate Investor is situated in the Zu00fcrich. The company was established in Europe in Switzerland.
The higher amount of exits for fund were in 2005. The important activity for fund was in 2001. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Swiss Life Private Equity Partners performs on 71 percentage points more the average number of lead investments.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Swiss Life Private Equity Partners, startups are often financed by Techno Venture Management, Oxford Bioscience Partners, Advent International. The meaningful sponsors for the fund in investment in the same round are Techno Venture Management, Yasuda Enterprise Development, Wheatley MedTech Partners. In the next rounds fund is usually obtained by Western Technology Investment, Thuja Capital, Techno Venture Management.
Among the most popular fund investment industries, there are Health Care, Manufacturing. Among the most popular portfolio startups of the fund, we may highlight Zeptosens, Phenex Pharmaceuticals, Enanta Pharmaceuticals. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Investor highlights
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 7
- Lead investments
- 0
- Exits
- 6
- Rounds per year
- 0.04
- Follow on index
- 0.14
- Investments by industry
- Biotechnology (4)
- Health Care (3)
- Pharmaceutical (2)
- Risk Management (2)
- Information Technology (2) Show 7 more
- Investments by region
-
- United States (5)
- Switzerland (1)
- Germany (1)
- Peak activity year
- 2001
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Avg. valuation at time of investment
- 553M
- Group Appearance index
- 1.00
- Avg. company exit year
- 8
- Avg. multiplicator
- 4.16
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| iolon, inc. | 25 Apr 2002 | Manufacturing, Optical Communication, Private Social Networking | Late Stage Venture | 7M | United States, California, San Jose |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.